ATE206760T1 - Transgenes, vernetztes hämoglobin - Google Patents

Transgenes, vernetztes hämoglobin

Info

Publication number
ATE206760T1
ATE206760T1 AT92903512T AT92903512T ATE206760T1 AT E206760 T1 ATE206760 T1 AT E206760T1 AT 92903512 T AT92903512 T AT 92903512T AT 92903512 T AT92903512 T AT 92903512T AT E206760 T1 ATE206760 T1 AT E206760T1
Authority
AT
Austria
Prior art keywords
transgenic
cross
human
hemoglobins
linked hemoglobin
Prior art date
Application number
AT92903512T
Other languages
English (en)
Inventor
Tim M Townes
Steven L Mccune
Original Assignee
Univ Alabama Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alabama Res Found filed Critical Univ Alabama Res Found
Application granted granted Critical
Publication of ATE206760T1 publication Critical patent/ATE206760T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92903512T 1990-12-20 1991-12-20 Transgenes, vernetztes hämoglobin ATE206760T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63082590A 1990-12-20 1990-12-20
PCT/US1991/009624 WO1992011283A1 (en) 1990-12-20 1991-12-20 Transgenic, cross-linked hemoglobin

Publications (1)

Publication Number Publication Date
ATE206760T1 true ATE206760T1 (de) 2001-10-15

Family

ID=24528700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903512T ATE206760T1 (de) 1990-12-20 1991-12-20 Transgenes, vernetztes hämoglobin

Country Status (7)

Country Link
EP (1) EP0668909B1 (de)
JP (1) JPH06504056A (de)
AT (1) ATE206760T1 (de)
AU (1) AU668856B2 (de)
CA (1) CA2098818A1 (de)
DE (1) DE69132763D1 (de)
WO (1) WO1992011283A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022849A (en) * 1987-05-16 2000-02-08 Baxter Biotech Technology Saarl Mutant recombinant hemoglobins containing heme pocket mutations
US6204009B1 (en) 1988-05-16 2001-03-20 BAXTER BIOTECH TECHNOLOGY SàRL Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations
US5844090A (en) * 1994-05-09 1998-12-01 Somatogen, Inc. Modified hemoglobin-like compounds
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
US6150506A (en) * 1989-05-10 2000-11-21 Baxter Biotech Technology Sarl Modified hemoglobin-like compounds and methods of purifying same
ATE225370T1 (de) 1993-03-31 2002-10-15 Pro Neuron Inc Inhibitor der stammzellproliferation und seine verwendung
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5840851A (en) * 1993-07-23 1998-11-24 Plomer; J. Jeffrey Purification of hemoglobin
US5578564A (en) * 1993-07-23 1996-11-26 Somatogen, Inc. Nickel-free hemoglobin and methods for producing such hemoglobin
IS4198A (is) * 1993-08-13 1995-02-14 Somatogen, Inc Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
US5665869A (en) * 1993-11-15 1997-09-09 Somatogen, Inc. Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
JPH11514237A (ja) * 1995-10-23 1999-12-07 ライス ユニバーシティ ヘム損失を減少させるヘモグロビン変異体
US6812207B1 (en) 1995-10-23 2004-11-02 William Marsh Rice University Hemoglobin mutants that reduce heme loss
JP2000502058A (ja) * 1995-11-30 2000-02-22 ソマトジェン,インコーポレイテッド ヘモグロビン架橋の際の機能性制御のための方法
US6218513B1 (en) 1995-12-22 2001-04-17 Baxter Biotech Technology Sarl Globins containing binding domains
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US7504377B2 (en) 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2962731B2 (ja) * 1986-11-10 1999-10-12 バイオピュアー、コーポレーション 超純枠半合成代用血液
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
CA2050601C (en) * 1989-05-10 2000-09-19 Stephen J. Hoffman Production in bacteria and yeast of hemoglobin and analogues thereof

Also Published As

Publication number Publication date
EP0668909A1 (de) 1995-08-30
EP0668909B1 (de) 2001-10-10
AU9167891A (en) 1992-07-22
WO1992011283A1 (en) 1992-07-09
DE69132763D1 (de) 2001-11-15
EP0668909A4 (de) 1994-09-02
CA2098818A1 (en) 1992-06-21
AU668856B2 (en) 1996-05-23
JPH06504056A (ja) 1994-05-12

Similar Documents

Publication Publication Date Title
ATE206760T1 (de) Transgenes, vernetztes hämoglobin
EP0842266A4 (de) Transgenes schwein und schweinezellen, die humane hla-gene aufweisen
DK0510356T3 (da) Polyethylenglycolproteinkonjugater
DE3780293D1 (de) Herstellung von formgebend abgeschmolzenen austenitischen werkstoffbestandteilen.
DK0744891T3 (da) Transgene fibrinogener
DE69100607D1 (de) Zusammensetzung zur Herstellung von künstlicher Milch für Kälber und daraus hergestellte künstliche Milch für Kälber.
EP0655888A4 (de) Herstellung von humanen hämoglobin in transgenen schweinen.
DE3860646D1 (de) Thermoplastische siliconkautschukpfropfpolymerisate (i).
DE3881533D1 (de) Tiermedizinische zusammensetzung zur verhinderung von diarrhoe bei tieren.
ATE313256T1 (de) Transgene schweine
ES2014245B3 (es) Pinza de colgar ropa en material plastico de una sola pieza.
ATE142228T1 (de) Das protein curuculin und verwendung desselben
DE69210168D1 (de) Gelenkspielzeug, zum Beispiel als kleines Tier oder Puppe
DE68904336D1 (de) Anti-humankrebsproteinkomplexe, deren herstellung und verwendung.
SE9302169D0 (sv) Stoedanordning foer haest
NO870768D0 (no) Tilsetningsmiddel til dyrefor, fremgangsmaate for dets fremstilling og anvendelse i forblandinger.
NO892481D0 (no) Dyrefor og fremgangsmaate til pelletisering derav.
FI964917A7 (fi) Sellaisen hemoglobiinin tuottaminen, jossa on alfa:n kaltainen globiin i
FI905247A0 (fi) Dietmaterial.
ATE100923T1 (de) Leuchtenraster.
DE3888045D1 (de) Chirurgisches thermoplastisches Nahtmaterial.
DE69636172D1 (de) Herstellung von protein c in transgenen tieren
ATE197528T1 (de) Einsperrgitter mit absperrungen
Yoon et al. Major Hemolymph Proteins and Vitellogenin in Mulberry Longicorn Beetle, Apriona germari Hope
RU93037923A (ru) Способ отбора овец романовской породы, устойчивых к аденоматозу

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties